← Database
REV-ERB Agonist

SR-9009

Third-party suppliers · research use only · not an endorsement. Some links are affiliate links — purchases made through them may earn this site a commission.
Overview

A circadian-clock (REV-ERB) agonist with metabolic effects in mice, but very poor oral bioavailability and no human evidence.

How it works

SR-9009 (stenabolic) targets a different system entirely: it activates REV-ERB, a protein that's part of the body's internal clock (circadian system) and also regulates metabolism.

By switching on REV-ERB, it represses certain clock and metabolic genes and increases mitochondrial activity in rodents, producing endurance- and metabolism-related effects in those models.

Two big caveats: it has very poor oral absorption, which undermines the marketed oral products, and there's no human data at all. It's also banned in sport. Much of its 'fat-burner' reputation outruns its actual, mostly-rodent and poorly-absorbed, evidence.

Mechanism · Detailed Analysis
Molecular targetAn agonist of the REV-ERBα/β nuclear receptors, components of the circadian clock.
Signaling & downstream effectsRepresses clock and metabolic target genes (e.g., Bmal1) and increases mitochondrial activity in rodents.
PharmacokineticsVery poor oral bioavailability — which undermines the pharmacology of marketed oral products.
CaveatsNo human data; banned in sport.
Published EvidenceLoading cited studies from PubMed…
Human Data ···

Searching the published record…

Animal ···

Searching the published record…

In Vitro ···

Searching the published record…

Educational aggregation of public literature. Not medical advice and not a recommendation to use any compound. Many compounds here are not approved for human use. Consult a licensed clinician.